4528 — Ono Pharmaceutical Co Share Price
Last trade - 00:00- ¥898bn
- ¥911bn
- ¥503bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 10.9 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -19.59% | ||
| Dividend Yield (f) | 4.18% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.11 | ||
| Price to Tang. Book | 2.25 | ||
| Price to Free Cashflow | 8.53 | ||
| Price to Sales | 1.79 | ||
| EV to EBITDA | 5.45 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.96% | ||
| Return on Equity | 15.38% | ||
| Operating Margin | 29.84% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 292,420 | 309,284 | 361,361 | 447,187 | 502,672 | 481,351 | 511,032 | 11.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +15.8 | +27.63 | +14.61 | +40.51 | +9.62 | -36.15 | +5.93 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
Directors
- Gyo Sagara PRE (62)
- Toichi Takino SME (53)
- Toshihiro Tsujinaka SME (56)
- Kiyoaki Idemitsu MEO (57)
- Isao Ono MEO (62)
- Shozo Matsuoka MEO (62)
- Yukio Tani MEO
- Hiromu Habashita EXO
- Hiroshi Ichikawa EXO (59)
- Masaki Ito EXO
- Keiji Masui EXO
- Shinji Takai EXO
- Katsuji Teranishi EXO
- Shusaku Nagae IND (71)
- Masao Nomura IND (72)
- Akiko Okuno IND (50)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- July 4th, 1947
- Public Since
- January 1st, 1962
- No. of Shareholders
- 70,897
- No. of Employees
- 3,853
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 469,644,728
- Address
- 1-8-2, Kyutaro-machi, Chuo-ku, OSAKA-SHI, 541-8564
- Web
- https://www.ono-pharma.com/
- Phone
- +81 662635670
- Auditors
- Deloitte Touche Tohmatsu LLC
Latest News for 4528
Upcoming Events for 4528
Q2 2025 Ono Pharmaceutical Co Ltd Earnings Release
Q3 2025 Ono Pharmaceutical Co Ltd Earnings Release
Similar to 4528
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
As of Today at 22:27 UTC, shares in Ono Pharmaceutical Co are trading at ¥1,912. This share price information is delayed by 15 minutes.
Shares in Ono Pharmaceutical Co last closed at ¥1,912 and the price had moved by -33.35% over the past 365 days. In terms of relative price strength the Ono Pharmaceutical Co share price has underperformed the Nikkei 225 Index by -44.18% over the past year.
The overall consensus recommendation for Ono Pharmaceutical Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ono Pharmaceutical Co dividend yield is 4.19% based on the trailing twelve month period.
Last year, Ono Pharmaceutical Co paid a total dividend of ¥80, and it currently has a trailing dividend yield of 4.19%.Looking ahead, shares in Ono Pharmaceutical Co are due to go ex-dividend on 2025-03-28 and the next dividend pay date is 2024-12-01.
Ono Pharmaceutical Co are due to go ex-dividend on 2025-03-28 and the next dividend pay date is 2024-12-01. The historic dividend yield on Ono Pharmaceutical Co shares is currently 4.19%.
To buy shares in Ono Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥1,912, shares in Ono Pharmaceutical Co had a market capitalisation of ¥898bn.
Here are the trading details for Ono Pharmaceutical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4528
Based on an overall assessment of its quality, value and momentum Ono Pharmaceutical Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ono Pharmaceutical Co is ¥2,225. That is 16.42% above the last closing price of ¥1,912.
Analysts covering Ono Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of ¥170 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ono Pharmaceutical Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -19.39%.
As of the last closing price of ¥1,912, shares in Ono Pharmaceutical Co were trading -17.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ono Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 10.9. The shares last closed at ¥1,912.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ono Pharmaceutical Co's management team is headed by:
- Gyo Sagara - PRE
- Toichi Takino - SME
- Toshihiro Tsujinaka - SME
- Kiyoaki Idemitsu - MEO
- Isao Ono - MEO
- Shozo Matsuoka - MEO
- Yukio Tani - MEO
- Hiromu Habashita - EXO
- Hiroshi Ichikawa - EXO
- Masaki Ito - EXO
- Keiji Masui - EXO
- Shinji Takai - EXO
- Katsuji Teranishi - EXO
- Shusaku Nagae - IND
- Masao Nomura - IND
- Akiko Okuno - IND